Naveen Pemmaraju: Honored to be invited to speak on Updates in BPDCN at Soho Italy in Rome, Italy this week!

Naveen Pemmaraju, made the following post on Twitter:

“Honored to be invited to speak on Updates in BPDCN at Soho Italy in Rome, Italy this week! Delighted to be joined by friends & colleagues from all over the world. A wonderful meeting with international exchange of ideas.”

Source: Naveen Pemmaraju/Twitter

Naveen Pemmaraju holds multiple positions at the University of Texas MD Anderson Cancer Center, including Executive Director of Cancer Medicine, the Director of the Leukemia – Cancer Network, and Professor in the Department of Leukemia. He is also the Director of the Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) program at the MDACC Leukemia Department. Dr. Pemmaraju’s clinical/translational research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), myeloproliferative neoplasms (MPN) and acute myeloid Leukemia (AML). Dr. Pemmaraju is also a well-known social media influencer.